Is it time to revisit our current hematopoietic progenitor cell quantification methods in the clinic?

Area of Science:

• Hematopoietic stem cell transplantation (HSCT)
• Cellular immunology
• Flow cytometry applications

Background:

• Current HSCT protocols rely on CD45 and CD34 expression for minimum cell counts.
• Earlier progenitor populations and differentiation stages within grafts are often overlooked.
• Thawed cell viability and function can vary significantly.

Purpose of the Study:

• To highlight the need for quantifying stem cell subpopulations in HSCT.
• To review existing data on antigen (Ag) combinations and functional markers.
• To identify applicable markers for routine clinical use.

Main Methods:

• Flow cytometry is used to quantify cells based on CD34, CD38, CD133, CD90 co-expression.
• Aldehyde dehydrogenase (ALDH) functional capacity is assessed.
• Analysis includes comparisons between bone marrow, peripheral blood, and cord blood grafts.

Main Results:

• Specific antigen combinations correlate with myeloid, erythroid, and platelet engraftment rates.
• Cell surface marker profiles can predict short-term versus long-term engraftment.
• Flow cytometry can assess post-thaw viability and identify mesenchymal stem cell phenotypes.

Conclusions:

• Quantifying stem cell subpopulations using specific markers and functional assays is essential for optimizing HSCT outcomes.
• Identifying key antigens and functional characteristics can enhance daily clinical practice.
• Further research into stem cell subpopulations can improve engraftment prediction and patient care.